• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Influence of MUC5B gene on antisynthetase syndrome.MUC5B 基因对抗合成酶综合征的影响。
Sci Rep. 2020 Jan 29;10(1):1415. doi: 10.1038/s41598-020-58400-0.
2
Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.自身免疫性肌炎患者 MUC5B 启动子变异与间质性肺病风险的探索。
Respir Med. 2017 Sep;130:52-54. doi: 10.1016/j.rmed.2017.07.010. Epub 2017 Jul 17.
3
promoter variant rs35705950, rare but significant susceptibility locus in rheumatoid arthritis-interstitial lung disease with usual interstitial pneumonia in Asian populations.启动子变异 rs35705950 是亚洲人群类风湿关节炎-寻常型间质性肺炎相关间质性肺病的罕见但重要的易感基因座。
RMD Open. 2022 Dec;8(2). doi: 10.1136/rmdopen-2022-002790.
4
MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.MUC5B 启动子变异 rs35705950 与类风湿关节炎相关的间质性肺病的生存和进展。
Semin Arthritis Rheum. 2021 Oct;51(5):996-1004. doi: 10.1016/j.semarthrit.2021.07.002. Epub 2021 Jul 10.
5
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.MUC5B 启动子变异与伴有间质性肺病的类风湿关节炎。
N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562. Epub 2018 Oct 20.
6
Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome.MUC1 rs4072037基因多态性和血清KL-6水平在抗合成酶综合征患者中的作用
Sci Rep. 2021 Nov 19;11(1):22574. doi: 10.1038/s41598-021-01992-y.
7
Interaction between the promoter polymorphism and mucin expression: is there a difference according to ILD subtype?启动子多态性与黏蛋白表达的相互作用:根据间质性肺病亚型是否存在差异?
Thorax. 2020 Oct;75(10):901-903. doi: 10.1136/thoraxjnl-2020-214579. Epub 2020 Jun 24.
8
The Association Between MUC5B Mutations and Clinical Outcome in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Retrospective Exploratory Study in China.中国类风湿关节炎相关间质性肺病患者 MUC5B 突变与临床结局的相关性:一项回顾性探索性研究。
Med Sci Monit. 2020 Mar 6;26:e920137. doi: 10.12659/MSM.920137.
9
Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in mutation carriers.突变携带者罹患类风湿关节炎相关间质性肺病的终身风险。
Ann Rheum Dis. 2021 Dec;80(12):1530-1536. doi: 10.1136/annrheumdis-2021-220698. Epub 2021 Aug 3.
10
Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males.粘蛋白5B启动子多态性与中国男性间质性肺疾病易感性相关。
PLoS One. 2014 Aug 14;9(8):e104919. doi: 10.1371/journal.pone.0104919. eCollection 2014.

引用本文的文献

1
Genetic Risk Factors in Idiopathic and Non-Idiopathic Interstitial Lung Disease: Similarities and Differences.特发性和非特发性间质性肺疾病的遗传风险因素:异同
Medicina (Kaunas). 2024 Nov 29;60(12):1967. doi: 10.3390/medicina60121967.
2
rs35705950 Promoter Variant Is Associated with Usual Interstitial Pneumonia in Patients with Antisynthetase Syndrome.rs35705950启动子变异与抗合成酶综合征患者的寻常型间质性肺炎相关。
J Clin Med. 2024 Oct 16;13(20):6159. doi: 10.3390/jcm13206159.
3
A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease.抗合成酶综合征相关间质性肺疾病综述
Int J Mol Sci. 2024 Apr 18;25(8):4453. doi: 10.3390/ijms25084453.
4
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.肺纤维化的遗传学和基因组学:描绘分子图谱,塑造精准医学。
Am J Respir Crit Care Med. 2024 Aug 15;210(4):401-423. doi: 10.1164/rccm.202401-0238SO.
5
Unusual presentation of antisynthetase syndrome: a case series and review of the literature.抗合成酶综合征的不典型表现:病例系列及文献复习。
J Med Case Rep. 2023 Jul 30;17(1):325. doi: 10.1186/s13256-023-04040-7.
6
The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.MUC5B 启动子多态性与非ILD 慢性呼吸道疾病或移植后结局无关。
Transpl Int. 2022 May 16;35:10159. doi: 10.3389/ti.2022.10159. eCollection 2022.
7
Defining anti-synthetase syndrome: a systematic literature review.抗合成酶综合征的定义:系统文献回顾。
Clin Exp Rheumatol. 2022 Feb;40(2):309-319. doi: 10.55563/clinexprheumatol/8xj0b9. Epub 2022 Feb 25.
8
The Promoter Polymorphism Associates With Severe COVID-19 in the European Population.启动子多态性与欧洲人群中的重症 COVID-19 相关。
Front Med (Lausanne). 2021 Nov 23;8:668024. doi: 10.3389/fmed.2021.668024. eCollection 2021.
9
Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome.MUC1 rs4072037基因多态性和血清KL-6水平在抗合成酶综合征患者中的作用
Sci Rep. 2021 Nov 19;11(1):22574. doi: 10.1038/s41598-021-01992-y.
10
Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response.进行性纤维化间质性肺疾病中的生物标志物:优化诊断、预后及治疗反应
Front Med (Lausanne). 2021 May 10;8:680997. doi: 10.3389/fmed.2021.680997. eCollection 2021.

本文引用的文献

1
Muco-Obstructive Lung Diseases.黏液阻塞性肺部疾病
N Engl J Med. 2019 May 16;380(20):1941-1953. doi: 10.1056/NEJMra1813799.
2
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study.甲襞毛细血管显微镜检查在抗合成酶综合征中的特征及其可能的临床关联:一项多中心国际研究的结果。
J Rheumatol. 2019 Mar;46(3):279-284. doi: 10.3899/jrheum.180355. Epub 2018 Nov 15.
3
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.MUC5B 启动子变异与伴有间质性肺病的类风湿关节炎。
N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562. Epub 2018 Oct 20.
4
Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.自身免疫性肌炎患者 MUC5B 启动子变异与间质性肺病风险的探索。
Respir Med. 2017 Sep;130:52-54. doi: 10.1016/j.rmed.2017.07.010. Epub 2017 Jul 17.
5
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.发病时间会影响抗合成酶综合征的关节炎表现模式。
Clin Exp Rheumatol. 2018 Jan-Feb;36(1):44-49. Epub 2017 Jul 26.
6
The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.慢性过敏性肺炎患者的 MUC5B 启动子多态性和端粒长度:一项观察性队列对照研究。
Lancet Respir Med. 2017 Aug;5(8):639-647. doi: 10.1016/S2213-2600(17)30216-3. Epub 2017 Jun 22.
7
Antifibrotic drugs as treatment of nonidiopathic pulmonary fibrosis interstitial pneumonias: the time is now (?).抗纤维化药物治疗非特发性肺纤维化间质性肺炎:时机已到(?)
Curr Opin Pulm Med. 2017 Sep;23(5):418-425. doi: 10.1097/MCP.0000000000000408.
8
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.抗-Jo1 阳性抗合成酶综合征疾病模式变化的临床随访预测因素:多中心、国际和回顾性研究的结果。
Autoimmun Rev. 2017 Mar;16(3):253-257. doi: 10.1016/j.autrev.2017.01.008. Epub 2017 Jan 29.
9
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.抗合成酶综合征中的血清 Jo-1 自身抗体和孤立性关节炎:文献复习及 AENEAS 协作组经验报告。
Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9.
10
Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD).一组抗合成酶综合征(ASS)患者的预后因素:血清学特征与间质性肺疾病(ILD)患者的死亡率相关。
Clin Rheumatol. 2015 Sep;34(9):1563-9. doi: 10.1007/s10067-015-3023-x. Epub 2015 Jul 30.

MUC5B 基因对抗合成酶综合征的影响。

Influence of MUC5B gene on antisynthetase syndrome.

机构信息

Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.

Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain.

出版信息

Sci Rep. 2020 Jan 29;10(1):1415. doi: 10.1038/s41598-020-58400-0.

DOI:10.1038/s41598-020-58400-0
PMID:31996780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6989632/
Abstract

MUC5B rs35705950 (G/T) is strongly associated with idiopathic pulmonary fibrosis (IPF) and also contributes to the risk of interstitial lung disease (ILD) in rheumatoid arthritis (RA-ILD) and chronic hypersensitivity pneumonitis (CHP). Due to this, we evaluated the implication of MUC5B rs35705950 in antisynthetase syndrome (ASSD), a pathology characterised by a high ILD incidence. 160 patients with ASSD (142 with ILD associated with ASSD [ASSD-ILD+]), 232 with ILD unrelated to ASSD (comprising 161 IPF, 27 RA-ILD and 44 CHP) and 534 healthy controls were genotyped. MUC5B rs35705950 frequency did not significantly differ between ASSD-ILD+ patients and healthy controls nor when ASSD patients were stratified according to the presence/absence of anti Jo-1 antibodies or ILD. No significant differences in MUC5B rs35705950 were also observed in ASSD-ILD+ patients with a usual interstitial pneumonia (UIP) pattern when compared to those with a non-UIP pattern. However, a statistically significant decrease of MUC5B rs35705950 GT, TT and T frequencies in ASSD-ILD+ patients compared to patients with ILD unrelated to ASSD was observed. In summary, our study does not support a role of MUC5B rs35705950 in ASSD. It also indicates that there are genetic differences between ILD associated with and that unrelated to ASSD.

摘要

MUC5B rs35705950(G/T)与特发性肺纤维化(IPF)强烈相关,也与类风湿关节炎(RA-ILD)和慢性过敏性肺炎(CHP)中的间质性肺病(ILD)风险相关。正因为如此,我们评估了 MUC5B rs35705950 在抗合成酶综合征(ASSD)中的意义,ASSD 是一种以高ILD 发生率为特征的疾病。我们对 160 名 ASSD 患者(142 名与 ASSD 相关的ILD [ASSD-ILD+],232 名与 ASSD 无关的ILD,包括 161 名 IPF、27 名 RA-ILD 和 44 名 CHP)和 534 名健康对照进行了基因分型。ASSD-ILD+患者与健康对照组之间,以及根据是否存在抗 Jo-1 抗体或ILD 对 ASSD 患者进行分层时,MUC5B rs35705950 的频率均无显著差异。在具有寻常型间质性肺炎(UIP)模式的 ASSD-ILD+患者与不具有 UIP 模式的患者相比,MUC5B rs35705950 也没有显著差异。然而,与ILD 无关的 ASSD 患者相比,ASSD-ILD+患者的 MUC5B rs35705950 GT、TT 和 T 频率显著降低。综上所述,我们的研究不支持 MUC5B rs35705950 在 ASSD 中的作用。这也表明与 ASSD 相关和不相关的ILD 之间存在遗传差异。